CNBC’s Jon Fortt joins ‘Power Lunch’ to discuss his interview with Dr. Michelle Longmire, Medable co-founder and CEO. Dr. Longmire explains her path to date and Medable’s efforts to transform medical research.
Clip available at:
https://www.cnbc.com/video/2021/11/01/medable-ceo-on-company-foundations-inspirations.html
Medable today announced today $304 million in Series D funding to accelerate global adoption of digital and decentralized clinical trials, enabling ubiquitous access to the latest treatments for every body and every biology. The funding round was co-led by new investors Blackstone Growth and Tiger Global and existing investor GSR Ventures. The round also includes follow-on investment from existing investors Sapphire Ventures and WTI. Congratulations to the Medable team!
https://finance.yahoo.com/news/medable-secures-304-million-funding-113700196.html
Inc. has honored HealthX Ventures in its annual Founder-Friendly Investors list, among the the venture capital and private equity firms with the best track record of success backing entrepreneurs. The final list recognizes firms that entrepreneurs can trust and collaborate with while receiving the financial support they need to help accelerate growth. All firms have a successful track record of remaining actively involved in the businesses after their investment.
Medable’s CEO, Dr. Michelle Longmire, has been named to Inc’s Female Founders 100 List. While practicing medicine and researching rare conditions Michelle had the idea for Medable; the solution for digitizing clinical trials has experienced explosive growth during the COVID-19 pandemic.
Read more about Michelle and Medable here: https://www.inc.com/profile/michelle-longmire
At HIMSS, Orbita announced a major upgrade to its award-winning conversational AI platform: its new Solution Center, which will be deployed with four healthcare systems. The new, turnkey Solution Center allows customers to quickly deploy secure, scalable omni-channel voice and virtual chatbot tools.
